Skip to main content

AEON Biopharma, Inc.

AEON
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001837607

In the last 90 days, AEON Biopharma, Inc. insiders filed 1 open-market purchase and 0 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $9.22M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding AEON Biopharma, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of AEON: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders4759+12
Shares13.1M17.6M+4.55M (+34.8%)
Value$126.0M$171.8M+$45.8M (+36.3%)

New holders (14)

Institutions that held AEON Biopharma, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to AEON in Q3 2021
InstitutionSharesValue% of portfolio
Empyrean Capital Partners, LP1,400,000$13.6M0.32%
HSBC Holdings PLC899,900$8.77M0.01%
Shaolin Capital Management LLC809,943$7.89M0.24%
CSS LLC335,000$3.26M0.17%
Arena Capital Advisors, LLC- CA249,600$2.43M0.19%
State of Wisconsin Investment Board160,000$1.56M0.00%
Echo Street Capital Management LLC100,000$975.0K0.01%
Segantii Capital Management Ltd50,000$488.0K0.02%
Highland Capital Management Fund Advisors, L.P.41,155$401.0K0.07%
Rivernorth Capital Management, LLC39,996$390.0K0.02%
Berkley W R Corp25,088$244.0K0.02%
Robinson Capital Management, LLC10,408$101.0K0.09%
Toroso Investments, LLC10,408$101.0K0.00%
683 Capital Management, LLC9,999$97.0K0.01%

Sold out (2)

Institutions that held AEON Biopharma, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of AEON in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Verition Fund Management LLC299,900$2.89M
Panagora Asset Management Inc792$8.00K